February 9, 2006-- Microvolt T-wave alternans (MTWA), an electrocardiographic (ECG) test that measures subtle variations in the heart beat, can identify heart disease patients who are either at high ...

UCSF is launching a remote patient monitoring program aimed at identifying arrhythmias in expectant mothers and improving detection, treatment and long-term care. Researchers at the University of ...

A recent study published in the journal Communications Medicine discusses how smartwatches can facilitate the diagnosis of arrhythmias in children. Study: Utility of smart watches for identifying ...

Partnership aims to utilize predictive AI to help identify arrhythmias earlier in patient populations with an elevated risk for arrhythmias to enable timely care for millions who remain undiagnosed ...

Researchers from two Lithuanian universities have developed a patient-safe monitoring technology to identify and manage individual factors provoking atrial fibrillation Researchers from two Lithuanian ...

A new paper published by Stanford University researchers in the nature Journal confirms the utility of smart watches for identifying arrhythmias in children. Arrhythmia symptoms are frequent ...

ATLANTA, Dec. 18, 2025 /PRNewswire/ -- Huxley Medical, Inc. announced the SANSA® home sleep apnea test has received regulatory clearance from the United States Food and Drug Administration (FDA) to be ...

Cardiovascular disease affects nearly half of the adults in the United States, posing a significant public health challenge. To improve the diagnosis and treatment of one such cardiac condition, Rui ...

BOSTON--(BUSINESS WIRE)--Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5–8 in Boston, ...

HeartBeam has secured two new US patents, strengthening its intellectual property (IP) portfolio in cardiac monitoring technology. The first patent pertains to the company’s cable-free ...

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent's has enrolled the first patient in the VITAL-EP study. The study is ...